Credelio Plus 225 mg (Lotilaner TABLET (CHEWABLE)) 225 MG

Credelio Plus 225 mg chewable tablets contain lotilaner, a parasitic treatment for dogs. This oral medication helps manage flea and tick infestations, ensuring your pet's comfort and health.

Strength

225 MG

Manufacturer / TM Owner

ELANCO CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Credelio Plus 225 mg chewable tablets are designed to treat and prevent flea and tick infestations in dogs. Lotilaner, the active ingredient, works to disrupt the parasites' nervous system, providing effective control. This medication is commonly used for managing external parasites, ensuring your pet's well-being.

Side Effects

Credelio Plus 225 mg chewable tablets may cause mild gastrointestinal upset in some dogs, such as vomiting or diarrhea. Some pets might also experience lethargy or decreased appetite. These effects are typically temporary and should subside as the body adjusts to the medication.

Precautions & Warnings

Always consult your veterinarian before administering Credelio Plus 225 mg chewable tablets to your dog. Ensure the correct dosage based on your pet's weight and follow the prescribed schedule. Store the medication in a cool, dry place away from children and other pets.

Avoid Interactions

Credelio Plus 225 mg chewable tablets may interact with other medications, including those metabolized by the liver. Inform your veterinarian about any other treatments your dog is receiving. Avoid administering this medication with other parasitic treatments unless directed by a professional.

Frequently Asked Questions

Credelio Plus 225 mg chewable tablets are used to treat and prevent flea and tick infestations in dogs.

Administer Credelio Plus 225 mg chewable tablets orally, following your veterinarian's instructions. Ensure your dog chews the tablet thoroughly.

Common side effects may include gastrointestinal upset, lethargy, and decreased appetite. These effects are usually temporary.

Consult your veterinarian before giving Credelio Plus 225 mg with other medications to avoid potential interactions.

Store Credelio Plus 225 mg chewable tablets in a cool, dry place away from children and other pets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.